BDBM329542 2-((1S,2S)-2-((2-methyl- 5-(pyridin-3- yl)pyrimidin-4- yloxy)methyl)cyclopropyl) quinoline::US9663513, 155
SMILES: Cc1ncc(c(OC[C@H]2C[C@@H]2c2ccc3ccccc3n2)n1)-c1cccnc1
InChI Key: InChIKey=CWMIVCRPGPZAHE-MOPGFXCFSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM329542 (2-((1S,2S)-2-((2-methyl- 5-(pyridin-3- yl)pyrimidi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description The fluorescence polarization assay for cyclic nucleotide phosphodiesterases was performed using an IMAP® FP kit supplied by Molecular Devices, Sunny... | US Patent US9663513 (2017) BindingDB Entry DOI: 10.7270/Q25D8TXC | |||||||||||
More data for this Ligand-Target Pair |